Brief: Sab Biotherapeutics Announces Departure Of Chief Financial Officer
SAB Biotherapeutics Inc SABS.O :
* SAB BIOTHERAPEUTICS ANNOUNCES DEPARTURE OF CHIEF FINANCIAL
OFFICER
* SAB BIOTHERAPEUTICS ANNOUNCES DEPARTURE OF CHIEF FINANCIAL
OFFICER
* SAB BIO'S CFO MICHAEL KING TO DEPART
* SAB BIO CONFIRMS 2024 FISCAL OUTLOOK
Source text for Eikon: ID:nGNX91MlWp
Further company coverage: SABS.O
Recent news on SAB Biotherapeutics
See all newsSAB Biotherapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
SAB Biotherapeutics Inc expected to post a loss of 29 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Ferrari, Hawkeye 360, Micron Technology
U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies
U.S. STOCKS ON THE MOVE-InspireMD, MiniMed, SoFi Technologies